{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:19:54Z","timestamp":1794277194114,"version":"4.9.0"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.2169\/internalmedicine.1862-23","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T22:16:17Z","timestamp":1706739377000},"page":"461-464","source":"Crossref","is-referenced-by-count":7,"title":["Immunoglobulin G4-related Dacryoadenitis Successfully Treated with Baricitinib"],"prefix":"10.2169","volume":"63","author":[{"given":"Atsuhiko","family":"Suenaga","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"},{"name":"Department of Nephrology, Saga University Internal Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Oba","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ikuma","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saga University Internal Medicine, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, the Cancer Institute Hospital of JFCR, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Kinowaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Miyazono","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Saga University Internal Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Yamaguchi's Pathology Laboratory, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yamamoto M, Yajima H, Takahashi H, et al. Everyday clinical practice in IgG4-related dacryoadenitis and\/or sialadenitis: results from the SMART database. Mod Rheumatol 25: 199-204, 2015.","DOI":"10.3109\/14397595.2014.950036"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sogabe Y, Ohshima K, Azumi A, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252: 531-538, 2014.","DOI":"10.1007\/s00417-013-2548-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Culver EL, Sadler R, Bateman AC, et al. Increases in IgE, eosinophils, and mast cells, can be used in diagnosis and to predict relapse of IgG4-related disease. Clin Gastroenterol Hepatol 15: 1444-1452.e6, 2017.","DOI":"10.1016\/j.cgh.2017.02.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Calabrese L, Malvaso D, Chiricozzi A, et al. Baricitinib: therapeutic potential for moderate to severe atopic dermatitis. Expert Opin Investig Drugs 29: 1089-1098, 2020.","DOI":"10.1080\/13543784.2020.1800639"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Klomjit N, Alexander MP, Fervenza FC, et al. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep 6: 2969-2978, 2021.","DOI":"10.1016\/j.ekir.2021.09.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Michailidou D, Schwartz DM, Mustelin T, Hughes GC. Allergic aspects of IgG4-related disease: implications for pathogenesis and therapy. Front Immunol 12: 693192, 2021.","DOI":"10.3389\/fimmu.2021.693192"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jorgensen SCJ, Tse CLY, Burry L, Dresser LD. Baricitinib: a review of pharmacology, safety, and emerging clinical experience in COVID-19. Pharmacotherapy 40: 843-856, 2020.","DOI":"10.1002\/phar.2438"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Khan S, Gordins P, Durairaj S. JAK inhibition as a therapeutic strategy for IgG4-RD. J Investig Allergol Clin Immunol 31: 280-281, 2021.","DOI":"10.18176\/jiaci.0654"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Kanda M, Kamekura R, Sugawara M, et al. IgG4-related disease administered dupilumab: case series and review of the literature. RMD Open 9: e003026, 2023.","DOI":"10.1136\/rmdopen-2023-003026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yu T, Wu Y, Liu J, Zhuang Y, Jin X, Wang L. The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis. Arthritis Res Ther 24: 14, 2022.","DOI":"10.1186\/s13075-021-02652-2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/3\/63_1862-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:30:53Z","timestamp":1715574653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/3\/63_1862-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1862-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"article-number":"1862-23"}}